Skip to main content

. 1990 Jun 23;300(6740):1626–1627. doi: 10.1136/bmj.300.6740.1626

Changes in determinants of blood rheology during treatment with haemodialysis and recombinant human erythropoietin.

R Koppensteiner ¹, F Stockenhuber ¹, C Jahn ¹, P Balcke ¹, E Minar ¹, H Ehringer ¹

PMCID: PMC1663271 PMID: 2372642

1626

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

HARKNESS J. A new instrument for the measurement of plasma-viscosity. Lancet. 1963 Aug 10;2(7302):280–281. doi: 10.1016/s0140-6736(63)90177-6. [DOI] [PubMed] [Google Scholar]
Winearls C. G., Oliver D. O., Pippard M. J., Reid C., Downing M. R., Cotes P. M. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet. 1986 Nov 22;2(8517):1175–1178. doi: 10.1016/s0140-6736(86)92192-6. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES